Open AccessFosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens
Author(s) -
Sayantan Banerjee,
Mallika Sengupta,
Tanoy Kumer Sarker
Publication year - 2017
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/iju.iju_285_16
Subject(s) - fosfomycin , medicine , beta lactamase , microbiology and biotechnology , multiple drug resistance , carbapenem , antibiotics , escherichia coli , genetics , biology , gene
Urinary tract infection (UTI) is one of the most common infectious diseases. With the emergence of multidrug resistance (MDR), therapeutic options for treatment of UTIs are becoming limited. Fosfomycin has emerged as a novel oral therapeutic option with bactericidal activity against the MDR uropathogens. We evaluated the susceptibility pattern of uropathogens to this antibiotic.